Patient | Antifungal therapy | Treatment of combined infection and underlying diseases | Antifungal course (month) | Outcome |
---|---|---|---|---|
P1 | voriconazole + amphotericin B + itraconazole | None | 51 | Improved |
P2 | voriconazole + itraconazole | None | 12 | No follow-up |
P3 | voriconazole + itraconazole | None | 12 | Improved |
P4 | voriconazole + itraconazole | Compound sulfamethoxazole | 12 | Improved |
P5 | amphotericin B + voriconazole + itraconazole | Regular intravenous Immunoglobulin, Compound sulfamethoxazole | 6 | No follow-up |
P6 | amphotericin B + voriconazole + itraconazole | Compound sulfamethoxazole, hemophagocytic lymphohistiocytosis treatment | 12 | Improved |